NDNF
Basic information
Region (hg38): 4:121035613-121073021
Previous symbols: [ "C4orf31" ]
Links
Phenotypes
GenCC
Source:
- Kallmann syndrome (Supportive), mode of inheritance: AD
- hypogonadotropic hypogonadism 25 with anosmia (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hypogonadotropic hypogonadism 25 with anosmia | AD | Endocrine | In Hypogonadotropic hypogonadism, surveillance in adolescence related to sexual maturation is indicated, as is monitoring of bone mineral density in order to allow early detection and treatment of disease; In order to induce and maintain secondary sex characteristics, gradually increasing doses of gonadal steroids (females: estrogen/progestin; males: testosterone/hCG) can be beneficial; Related to fertility, endocrinologic therapy (females: recombinant hCG or pulsatile GnRH therapy; males: hCG/HMG/recombinant FSH or pulsatile GnRH therapy) may be effective, though IVF may be required | Endocrine; Genitourinary; Neurologic | 20301509; 31883645 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (51 variants)
- Hypogonadotropic_hypogonadism_25_with_anosmia (8 variants)
- not_provided (1 variants)
- NDNF-related_condition (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NDNF gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024574.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 50 | 54 | ||||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 3 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 3 | 2 | 51 | 4 | 0 |
Highest pathogenic variant AF is 0.0000034203983
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| NDNF | protein_coding | protein_coding | ENST00000379692 | 3 | 37409 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.380 | 0.619 | 125725 | 0 | 9 | 125734 | 0.0000358 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.483 | 275 | 298 | 0.921 | 0.0000153 | 3731 |
| Missense in Polyphen | 60 | 78.36 | 0.76569 | 957 | ||
| Synonymous | -0.104 | 119 | 118 | 1.01 | 0.00000630 | 1103 |
| Loss of Function | 3.04 | 4 | 17.9 | 0.224 | 8.22e-7 | 250 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000126 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000444 | 0.0000440 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes matrix assembly and cell adhesiveness (By similarity). Promotes neuron migration, growth and survival as well as neurite outgrowth (PubMed:20969804). Promotes endothelial cell survival, vessel formation and plays an important role in the process of revascularization through NOS3-dependent mechanisms (PubMed:24706764). {ECO:0000250|UniProtKB:Q8C119, ECO:0000269|PubMed:20969804, ECO:0000269|PubMed:24706764}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.86
Haploinsufficiency Scores
- pHI
- 0.615
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ndnf
- Phenotype
Zebrafish Information Network
- Gene name
- ndnf
- Affected structure
- neurocranium
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- angiogenesis;neuron migration;response to ischemia;nitric oxide mediated signal transduction;positive regulation of cell-substrate adhesion;positive regulation of neuron projection development;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix organization;negative regulation of neuron apoptotic process;vascular wound healing;cellular response to hypoxia;negative regulation of endothelial cell apoptotic process
- Cellular component
- extracellular region;extracellular matrix
- Molecular function
- glycosaminoglycan binding;heparin binding